ReviewFrontiers in pharmacology2023

Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer.

Huafeng Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.